However, these cutting-edge therapies are often moisture- and temperature-sensitive, presenting new packaging and containment challenges.
To ensure optimised storage and moisture protection for their injectable drug products, biopharmaceutical companies are increasingly turning to the process of lyophilisation for biologics and other drugs that are sensitive in liquid form or sensitive to their environment.
Lyophilisation is considered to be an ideal process for injectable drug products that may have a limited shelf-life in solution. Some drug formulations are unstable in aqueous solutions; the active ingredient can interact with, and degrade quickly in, water.